losartan has been researched along with Colitis, Mucous in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "Losartan prevented visceral allodynia and colonic hyperpermeability in rat IBS models." | 7.96 | Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome. ( Miyagishi, S; Nozu, R; Nozu, T; Okumura, T; Takakusaki, K, 2020) |
| " Losartan (Los) is known to reduce pain; however, its function in IBS is unclear." | 4.31 | Losartan attenuates acetic acid enema-induced visceral hypersensitivity by inhibiting the ACE1/Ang II/AT1 receptor axis in enteric glial cells. ( Chen, Y; Dai, F; Li, J; Li, L; Liu, X; Mei, L; Meng, R; Quan, X; Shi, H; Sun, Y; Wang, J; Wang, L; Wang, T; Zhang, Y, 2023) |
| "Losartan prevented visceral allodynia and colonic hyperpermeability in rat IBS models." | 3.96 | Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome. ( Miyagishi, S; Nozu, R; Nozu, T; Okumura, T; Takakusaki, K, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, Y | 1 |
| Liu, X | 1 |
| Wang, L | 1 |
| Li, L | 1 |
| Quan, X | 1 |
| Shi, H | 1 |
| Wang, T | 1 |
| Mei, L | 1 |
| Chen, Y | 1 |
| Zhang, Y | 1 |
| Li, J | 1 |
| Meng, R | 1 |
| Wang, J | 1 |
| Dai, F | 1 |
| Nozu, T | 1 |
| Miyagishi, S | 1 |
| Nozu, R | 1 |
| Takakusaki, K | 1 |
| Okumura, T | 1 |
2 other studies available for losartan and Colitis, Mucous
| Article | Year |
|---|---|
Losartan attenuates acetic acid enema-induced visceral hypersensitivity by inhibiting the ACE1/Ang II/AT1 receptor axis in enteric glial cells.
Topics: Acetic Acid; Animals; Enema; Irritable Bowel Syndrome; Lipopolysaccharides; Losartan; Neuroglia; Pai | 2023 |
Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
Topics: Animals; Colon; Corticotropin-Releasing Hormone; Disease Models, Animal; Hyperalgesia; Irritable Bow | 2020 |